Potential Cost-Effectiveness of Supervised Injection Facilities in Toronto and Ottawa, Canada
BACKGROUND AND AIMS:
Supervised
injection facilities (legally sanctioned spaces for supervised consumption of
illicitly obtained drugs) are controversial public health interventions. We
determined the optimal number of facilities in two Canadian cities using health
economic methods.
DESIGN:
Dynamic
compartmental model of HIV and hepatitis C transmission through sexual contact
and sharing of drug use equipment.
MEASUREMENTS:
Direct
health-care costs and quality-adjusted life-years (QALYs) over 20 years,
discounted at 5% per year; incremental cost-effectiveness ratios.
FINDINGS:
In
Toronto, one facility cost $4.1 million and resulted in a gain of 385 QALYs
over 20 years, for an incremental cost-effectiveness ratio (ICER) of $10 763
per QALY [95% credible interval (95CrI): cost-saving to $278 311]. Establishing
one facility in Ottawa had an ICER of $6127 per QALY (95CrI: cost-saving to
$179 272). At a $50 000 per QALY threshold, three facilities would be
cost-effective in Toronto and two in Ottawa. The probability that establishing
three, four, or five facilities in Toronto was cost-effective was 17, 21, and
41%, respectively. Establishing one, two, or three facilities in Ottawa was
cost-effective with 13, 35, and 41% probability, respectively. Establishing no
facility was unlikely to be the most cost-effective option (14% in Toronto and
10% in Ottawa). In both cities, results were robust if the reduction in
needle-sharing among clients of the facilities was at least 50% and fixed
operating costs were less than $2.0 million.
CONCLUSIONS:
Using
a $50 000 per quality-adjusted life-years threshold for cost-effectiveness, it
is likely to be cost-effective to establish at least three legally sanctioned
spaces for supervised injection of illicitly obtained drugs in Toronto, Canada
and two in Ottawa, Canada.
- 1Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN, USA.
- 2Ivey Business School, Western University, London, ON, Canada.
- 3Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
- 4Center for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada.
- 5Centre for Research on Inner City Health, Li KaShing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.
- 6Department of Medicine, University of Toronto, Toronto, ON, Canada.
- 7Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
- 8Division of General Internal Medicine, St Michael's Hospital, Toronto, ON, Canada.
No comments:
Post a Comment